---
figid: PMC6387269__ijms-20-00728-g003
figlink: /pmc/articles/PMC6387269/figure/ijms-20-00728-f003/
number: Figure 3
caption: 'Potential for using mTOR in PD treatment. (a) Inhibition of mTOR signaling,
  through pharmacological blockade of mTOR or reduction of Rhes, provides a better
  stage for the L-DOPA therapy of PD. (b) The induction of autophagy by either mTOR-dependent
  or -independent pathway, enhances the degradation of toxic α-synuclein to alleviate
  the symptoms of PD. (c) Activation of Akt or Rheb, specific ablation of PTEN or
  overexpression of miR-7 and miR-153 could increase mTOR signaling to prevent neuron
  cell death. Furthermore, a balance between activation of mTOR signaling and enhancement
  of autophagy needs to be accurately managed in the treatment of PD. Abbreviations:
  PD, Parkinson''s disease; Rhes, Ras homolog enriched in striatum; Rheb, Ras homolog
  enriched in brain; miR, MicroRNA.'
pmcid: PMC6387269
papertitle: Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s
  Disease.
reftext: Zhou Zhu, et al. Int J Mol Sci. 2019 Feb;20(3):728.
pmc_ranked_result_index: '13863'
pathway_score: 0.8779799
filename: ijms-20-00728-g003.jpg
figtitle: For using mTOR in PD treatment
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6387269__ijms-20-00728-g003.html
  '@type': Dataset
  description: 'Potential for using mTOR in PD treatment. (a) Inhibition of mTOR signaling,
    through pharmacological blockade of mTOR or reduction of Rhes, provides a better
    stage for the L-DOPA therapy of PD. (b) The induction of autophagy by either mTOR-dependent
    or -independent pathway, enhances the degradation of toxic α-synuclein to alleviate
    the symptoms of PD. (c) Activation of Akt or Rheb, specific ablation of PTEN or
    overexpression of miR-7 and miR-153 could increase mTOR signaling to prevent neuron
    cell death. Furthermore, a balance between activation of mTOR signaling and enhancement
    of autophagy needs to be accurately managed in the treatment of PD. Abbreviations:
    PD, Parkinson''s disease; Rhes, Ras homolog enriched in striatum; Rheb, Ras homolog
    enriched in brain; miR, MicroRNA.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - PTEN
  - C1QA
  - AKT3
  - C1S
  - AKT2
  - LILRB1
  - C1QB
  - C1QC
  - C1R
  - RASD2
  - RHEB
  - AKT1
  - L-DOPA
  - Rapamycin
  - rapamycin
  - curcumin
  - piperine
  - lithium
  - trehalose
  - dyskinesia
  - Parkinson's
genes:
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QA
  entrez: '712'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1S
  entrez: '716'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: miR-7,
  symbol: MIR-7
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB1
  entrez: '10859'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QB
  entrez: '713'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QC
  entrez: '714'
- word: C1
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1R
  entrez: '715'
- word: Rhes
  symbol: Rhes
  source: hgnc_alias_symbol
  hgnc_symbol: RASD2
  entrez: '23551'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: L-DOPA
  source: MESH
  identifier: D007980
- word: Rapamycin
  source: MESH
  identifier: D020123
- word: rapamycin
  source: MESH
  identifier: D020123
- word: curcumin
  source: MESH
  identifier: D003474
- word: piperine
  source: MESH
  identifier: C008922
- word: lithium
  source: MESH
  identifier: D008094
- word: trehalose
  source: MESH
  identifier: D014199
diseases:
- word: dyskinesia
  source: MESH
  identifier: D004409
- word: Parkinson's
  source: MESH
  identifier: D010300
---
